Evolving intricacies and implications of E2F1 regulation.
about
EAPP, a novel E2F binding protein that modulates E2F-dependent transcriptionCamptothecin induces nuclear export of prohibitin preferentially in transformed cells through a CRM-1-dependent mechanismRetinoblastoma family genesMolecular determinants for the complex formation between the retinoblastoma protein and LXCXE sequencesA computational genomics approach to identify cis-regulatory modules from chromatin immunoprecipitation microarray data--a case study using E2F1Human herpesvirus 6A (HHV-6A) and HHV-6B alter E2F1/Rb pathways and E2F1 localization and cause cell cycle arrest in infected T cellsHuman herpesvirus 6 (HHV-6) alters E2F1/Rb pathways and utilizes the E2F1 transcription factor to express viral genes.GNL3L Is a Nucleo-Cytoplasmic Shuttling Protein: Role in Cell Cycle Regulation.Pathway aberrations of murine melanoma cells observed in Paired-End diTag transcriptomes.Cyclin D1 as a therapeutic target of renal cell carcinoma- a combined transcriptomics, tissue microarray and molecular docking study from the Kingdom of Saudi Arabia.Senescence sensitivity of breast cancer cells is defined by positive feedback loop between CIP2A and E2F1.The targeting and functions of miRNA-383 are mediated by FMRP during spermatogenesis.Effects of excretory/secretory products from Clonorchis sinensis and the carcinogen dimethylnitrosamine on the proliferation and cell cycle modulation of human epithelial HEK293T cells.Genistein targets the cancerous inhibitor of PP2A to induce growth inhibition and apoptosis in breast cancer cells.The role of the retinoblastoma/E2F1 tumor suppressor pathway in the lesion recognition step of nucleotide excision repair.Transcription addiction: can we garner the Yin and Yang functions of E2F1 for cancer therapy?The potential role of PD0332991 (Palbociclib) in the treatment of multiple myeloma.Overexpression of the replication licensing regulators hCdt1 and hCdc6 characterizes a subset of non-small-cell lung carcinomas: synergistic effect with mutant p53 on tumor growth and chromosomal instability--evidence of E2F-1 transcriptional controDeregulated microRNA expression and its pathogenetic implications for myelodysplastic syndromes.Modern principles of classification and development of nutrient media for culturing of human and animal cells.Caffeic acid phenethyl ester induces E2F-1-mediated growth inhibition and cell-cycle arrest in human cervical cancer cells.Specific role for p300/CREB-binding protein-associated factor activity in E2F1 stabilization in response to DNA damage.Expression of Itch in Sertoli cells is controlled via the interaction of E2F1/DP1 complex with E2F and GATA motifs.Second generation tyrosine kinase inhibitors prevent disease progression in high-risk (high CIP2A) chronic myeloid leukaemia patients.Combined analysis identifies six genes correlated with augmented malignancy from non-small cell to small cell lung cancer.Chemerin, a novel peroxisome proliferator-activated receptor gamma (PPARgamma) target gene that promotes mesenchymal stem cell adipogenesis.Hypoxia induces major effects on cell cycle kinetics and protein expression in Drosophila melanogaster embryos.Abnormal cell cycle regulation in primary human uveal melanoma cultures.Role of differential and cell type-specific expression of cell cycle regulatory proteins in mediating progressive glomerular injury in human IgA nephropathy.
P2860
Q24295046-23915106-02CA-4770-AC73-E46F7084ED95Q24297530-AC2A987B-94A4-433B-B952-C614EC4FD66BQ24683690-FA65F8FC-9FE4-4DE6-91AA-B68113A398EEQ28268668-342D057B-291F-4CF4-B41A-5F9E7C627764Q31068338-8AEC9F55-75A0-4ACC-ABC2-D20ED134B885Q33301426-241D9D29-91B8-4514-95E2-D494FD52286AQ35066420-83B57E5B-D2C1-4F56-BE93-24F688C44596Q35746179-C6FEE7F1-C4D8-4681-A3BC-AB6B887330E2Q35906375-18136DF8-A86C-4A7F-BDA8-C2F31B419167Q36170317-88AFDC5D-D437-4F54-A8CF-0CDB0740C5E2Q36609038-80FC0A1A-5FE8-4FAC-B3FA-A45893194077Q36907062-16B8E3A4-6496-4544-83D0-A8EF0158A87EQ36908782-C6597C6A-20C2-4A4E-A371-F60599BEBA89Q37103978-A1609F6D-8359-4F66-B3CF-020FB5C4449DQ37237230-089F6FDF-11B6-4D62-9598-E2467772C9BCQ38237693-FE401648-D6CF-4932-8FBA-3F6E53839267Q38286180-1F959AD8-0A68-40F4-9202-27F54CB7C841Q38782589-8DE66269-D2AD-4EF4-B24A-C81CB5A1364DQ38880958-7E9631C7-5CEC-4B8F-A498-73846C98E493Q39152889-311C9495-4F0D-4A7A-87B8-6BCA1615144DQ39180672-5CB13476-7B5D-4A76-8E5E-084B0849E52BQ40559898-AD6EFB07-712B-43CA-B9F0-C4F7C6084325Q40830506-CFE68599-DF41-4C17-A31F-A1F3E439F4BDQ41234743-859FA51C-9A55-4724-9D1E-1FF722116C4BQ41389873-D2F017B6-EB85-474D-A906-5726C948963CQ42785697-CDF02CDB-90F5-45F6-89AB-4624FCB0A00FQ45119438-99B3867C-EBE1-4591-B407-80910AF11B27Q45231167-448244F8-5278-454A-9ADE-11260F05B218Q47314961-12894267-257F-4AD8-869D-C01B22BDC96F
P2860
Evolving intricacies and implications of E2F1 regulation.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Evolving intricacies and implications of E2F1 regulation.
@ast
Evolving intricacies and implications of E2F1 regulation.
@en
type
label
Evolving intricacies and implications of E2F1 regulation.
@ast
Evolving intricacies and implications of E2F1 regulation.
@en
prefLabel
Evolving intricacies and implications of E2F1 regulation.
@ast
Evolving intricacies and implications of E2F1 regulation.
@en
P356
P1433
P1476
Evolving intricacies and implications of E2F1 regulation.
@en
P2093
Gurveen Saberwal
Suneel D Mundle
P304
P356
10.1096/FJ.02-0431REV
P407
P577
2003-04-01T00:00:00Z